Cerecetam
Indicated to address cerebral neurological deficits to relieve muscular myoclonus spasms and support cognitive function.
Cerecetam details
- Conditions
- Cognitive Impairment · Myoclonus
- Alternative names
- piracetam
- Therapeutic class
- Nootropic
- Pharmacological class
- GABA Derivative
- Known off-label uses
- dyslexia
- Contraindications
- severe renal impairment; huntington's chorea; cerebral haemorrhage
- Minor side effects
- nervousness; hyperkinesia; weight gain
- Moderate side effects
- insomnia; somnolence; depression
- Serious side effects
- severe bleeding disorder, requires immediate medical attention
- Dosage forms
- Tablet
- Administration route
- Oral use
- Supply category
- Prescription-only medicine (POM)
- Manufacturer
- Intas Pharmaceuticals
- Onset Time
- 30–60 minutes
- Duration
- 6–8 hours
- Storage instructions
- Store below 25°C.
- Drug interactions
- Thyroid Hormones; Warfarin
- Age restrictions
- Approved for adults and select paediatric populations.
Patient summary
indicated to address cerebral neurological deficits to relieve muscular myoclonus spasms and support cognitive function.
Mechanism of action
Modulates neurotransmission pathways and improves membrane fluidity of neuronal cells, optimising neuroplasticity.
Pregnancy and breastfeeding
TGA Category C: Avoid during pregnancy as safety is unconfirmed. Breastfeeding: Avoid.